SIMILAR PATTERNS OF AMINO ACIDS FOR 3GCS_A_BAXA401_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1cm8 PHOSPHORYLATED MAP
KINASE P38-GAMMA

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  54
LEU A  78
ILE A  87
ILE A 144
HIS A 151
 ANP  A 400 (-3.3A)
None
ANP  A 400 (-4.9A)
None
None
 0.98A 3gcsA-1cm8A:
24.5		 3gcsA-1cm8A:
60.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fot CAMP-DEPENDENT
PROTEIN KINASE TYPE
1

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		5 VAL A 101
ALA A 114
GLU A 135
LEU A 139
ILE A 148
 None
 0.89A 3gcsA-1fotA:
22.6		 3gcsA-1fotA:
25.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fot CAMP-DEPENDENT
PROTEIN KINASE TYPE
1

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		5 VAL A 101
ALA A 114
LEU A 139
ILE A 148
ASP A 228
 None
 1.00A 3gcsA-1fotA:
22.6		 3gcsA-1fotA:
25.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ldj CULLIN HOMOLOG 1

(Homo sapiens) 		PF00888
(Cullin)
PF10557
(Cullin_Nedd8) 		5 VAL A 734
ALA A 714
ARG A 764
LEU A 762
ASP A 754
 None
 0.92A 3gcsA-1ldjA:
undetectable		 3gcsA-1ldjA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nlf REGULATORY PROTEIN
REPA

(Escherichia
coli) 		PF13481
(AAA_25) 		5 ALA A 130
LEU A 142
LEU A 139
ILE A 174
ILE A 206
 None
 0.94A 3gcsA-1nlfA:
undetectable		 3gcsA-1nlfA:
22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ozn RETICULON 4 RECEPTOR

(Homo sapiens) 		PF13855
(LRR_8) 		5 VAL A 217
ALA A 245
ARG A 206
LEU A 228
LEU A 255
 None
 1.01A 3gcsA-1oznA:
undetectable		 3gcsA-1oznA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t46 HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 621
LEU A 644
THR A 670
HIS A 790
ASP A 810
 STI  A   3 (-3.5A)
STI  A   3 (-4.4A)
STI  A   3 (-3.2A)
STI  A   3 (-4.5A)
STI  A   3 (-3.9A)
 0.78A 3gcsA-1t46A:
19.5		 3gcsA-1t46A:
25.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t46 HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 603
ALA A 621
LEU A 647
LEU A 644
THR A 670
 STI  A   3 ( 4.6A)
STI  A   3 (-3.5A)
None
STI  A   3 (-4.4A)
STI  A   3 (-3.2A)
 0.98A 3gcsA-1t46A:
19.5		 3gcsA-1t46A:
25.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ua2 CELL DIVISION
PROTEIN KINASE 7

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 204
LEU A 153
LEU A 143
HIS A 129
ASP A 195
 None
 0.93A 3gcsA-1ua2A:
24.7		 3gcsA-1ua2A:
33.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xhn CELLULAR REPRESSOR
OF E1A-STIMULATED
GENES

(Homo sapiens) 		PF13883
(Pyrid_oxidase_2) 		5 VAL A 181
ALA A  20
LEU A  89
LEU A 116
ILE A 114
 None
 0.90A 3gcsA-1xhnA:
undetectable		 3gcsA-1xhnA:
17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y4u CHAPERONE PROTEIN
HTPG

(Escherichia
coli) 		PF00183
(HSP90)
PF02518
(HATPase_c) 		5 VAL A  65
ALA A  39
ARG A 236
LEU A 233
ASP A 202
 None
 0.86A 3gcsA-1y4uA:
undetectable		 3gcsA-1y4uA:
23.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zws DAP-KINASE RELATED
PROTEIN 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  27
ALA A  40
GLU A  64
LEU A  68
ILE A  77
 None
 1.00A 3gcsA-1zwsA:
22.1		 3gcsA-1zwsA:
28.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2aaa ALPHA-AMYLASE

(Aspergillus
niger) 		PF00128
(Alpha-amylase)
PF09260
(DUF1966) 		5 VAL A  90
LEU A 107
LEU A 114
ILE A  62
ILE A  52
 None
 0.99A 3gcsA-2aaaA:
undetectable		 3gcsA-2aaaA:
21.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2b1p MITOGEN-ACTIVATED
PROTEIN KINASE 10

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  78
ALA A  91
ILE A 124
HIS A 187
ASP A 207
 AIZ  A 501 ( 4.7A)
AIZ  A 501 (-3.4A)
None
None
None
 0.81A 3gcsA-2b1pA:
34.5		 3gcsA-2b1pA:
48.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c5u RNA LIGASE

(Escherichia
virus T4) 		PF09511
(RNA_lig_T4_1) 		5 VAL A 181
LEU A 134
ILE A 114
THR A 107
ASP A 144
 None
 0.83A 3gcsA-2c5uA:
undetectable		 3gcsA-2c5uA:
24.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h21 RIBULOSE-1,5
BISPHOSPHATE
CARBOXYLASE/OXYGENAS
E

(Pisum sativum) 		PF00856
(SET)
PF09273
(Rubis-subs-bind) 		5 ALA A 341
LEU A 361
ILE A 318
LEU A 329
ASP A 330
 None
 0.92A 3gcsA-2h21A:
undetectable		 3gcsA-2h21A:
24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hen EPHRIN TYPE-B
RECEPTOR 2

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		6 VAL A 643
ALA A 659
ILE A 691
THR A 707
HIS A 752
ASP A 772
 ADP  A 400 ( 4.4A)
ADP  A 400 (-3.2A)
None
ADP  A 400 (-4.7A)
None
ADP  A 400 ( 4.8A)
 1.25A 3gcsA-2henA:
13.5		 3gcsA-2henA:
25.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hk5 TYROSINE-PROTEIN
KINASE HCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 259
ALA A 271
GLU A 288
THR A 316
ILE A 355
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 (-3.2A)
None
 0.80A 3gcsA-2hk5A:
17.7		 3gcsA-2hk5A:
24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hk5 TYROSINE-PROTEIN
KINASE HCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 259
ALA A 271
THR A 316
ILE A 355
HIS A 362
 1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
None
None
 0.87A 3gcsA-2hk5A:
17.7		 3gcsA-2hk5A:
24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 271
GLU A 288
THR A 316
HIS A 362
ASP A 382
 1N8  A 501 ( 3.4A)
1N8  A 501 ( 3.6A)
1N8  A 501 ( 3.3A)
None
1N8  A 501 ( 3.3A)
 0.87A 3gcsA-2og8A:
20.9		 3gcsA-2og8A:
26.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 271
LEU A 291
THR A 316
ILE A 355
HIS A 362
ASP A 382
 1N8  A 501 ( 3.4A)
None
1N8  A 501 ( 3.3A)
None
None
1N8  A 501 ( 3.3A)
 0.84A 3gcsA-2og8A:
20.9		 3gcsA-2og8A:
26.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 259
ALA A 271
LEU A 291
THR A 316
ILE A 355
HIS A 362
 None
1N8  A 501 ( 3.4A)
None
1N8  A 501 ( 3.3A)
None
None
 0.95A 3gcsA-2og8A:
20.9		 3gcsA-2og8A:
26.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 VAL A 838
ALA A 853
LEU A 879
LEU A 876
ILE A 886
HIS A 962
ASP A 982
 MR9  A 301 (-4.6A)
MR9  A 301 (-3.5A)
MR9  A 301 (-4.1A)
MR9  A 301 ( 4.5A)
MR9  A 301 (-4.0A)
MR9  A 301 (-4.5A)
MR9  A 301 (-4.2A)
 1.36A 3gcsA-2p4iA:
17.3		 3gcsA-2p4iA:
26.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pjz HYPOTHETICAL PROTEIN
ST1066

(Sulfurisphaera
tokodaii) 		PF00005
(ABC_tran) 		6 ALA A 142
GLU A  82
LEU A  53
THR A  78
ILE A   9
LEU A  47
 None
 1.38A 3gcsA-2pjzA:
undetectable		 3gcsA-2pjzA:
23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qob EPHRIN RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 635
ALA A 651
GLU A 670
ILE A 683
THR A 699
 BME  A   1 (-4.9A)
PTR  A 701 ( 4.7A)
None
None
None
 0.89A 3gcsA-2qobA:
20.7		 3gcsA-2qobA:
25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qob EPHRIN RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 635
ALA A 651
ILE A 683
THR A 699
HIS A 744
 BME  A   1 (-4.9A)
PTR  A 701 ( 4.7A)
None
None
None
 0.99A 3gcsA-2qobA:
20.7		 3gcsA-2qobA:
25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus musculus) 		PF00069
(Pkinase) 		5 ALA A 449
GLU A 463
LEU A 467
ILE A 477
THR A 493
 None
 0.92A 3gcsA-2qr7A:
18.9		 3gcsA-2qr7A:
29.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus musculus) 		PF00069
(Pkinase) 		5 ALA A 449
LEU A 467
ILE A 477
THR A 493
HIS A 537
 None
 0.94A 3gcsA-2qr7A:
18.9		 3gcsA-2qr7A:
29.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r51 VACUOLAR PROTEIN
SORTING-ASSOCIATED
PROTEIN 26B

(Mus musculus) 		PF03643
(Vps26) 		5 VAL A 148
ALA A  25
LEU A 292
LEU A 185
ILE A 209
 None
 0.99A 3gcsA-2r51A:
undetectable		 3gcsA-2r51A:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wda PUTATIVE SECRETED
LYASE

(Streptomyces
violaceoruber) 		PF02278
(Lyase_8)
PF02884
(Lyase_8_C)
PF08124
(Lyase_8_N) 		6 ALA A 157
LEU A  94
ILE A 118
THR A  98
LEU A 119
ASP A 123
 None
 1.35A 3gcsA-2wdaA:
undetectable		 3gcsA-2wdaA:
19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wiz ARCHAEAL HJC

(Archaeoglobus
fulgidus) 		PF01870
(Hjc) 		5 LEU A  13
LEU A  12
ILE A  50
ILE A  24
LEU A  48
 None
 0.92A 3gcsA-2wizA:
undetectable		 3gcsA-2wizA:
17.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2wnt RIBOSOMAL PROTEIN S6
KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 445
GLU A 459
LEU A 463
ILE A 473
THR A 489
 None
 0.98A 3gcsA-2wntA:
18.8		 3gcsA-2wntA:
30.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtb FATTY ACID
MULTIFUNCTIONAL
PROTEIN (ATMFP2)

(Arabidopsis
thaliana) 		PF00378
(ECH_1)
PF00725
(3HCDH)
PF02737
(3HCDH_N) 		6 VAL A 273
ALA A 254
GLU A 139
LEU A 137
ILE A 167
THR A 151
 None
 1.46A 3gcsA-2wtbA:
undetectable		 3gcsA-2wtbA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtk SERINE/THREONINE-PRO
TEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL C  63
ALA C  76
GLU C  98
LEU C 102
ILE C 111
 ANP  C   2 (-4.2A)
ANP  C   2 (-3.4A)
None
None
None
 0.97A 3gcsA-2wtkC:
21.4		 3gcsA-2wtkC:
28.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x1m METHIONYL-TRNA
SYNTHETASE

(Mycolicibacterium
smegmatis) 		PF09334
(tRNA-synt_1g) 		5 VAL A 156
ALA A 154
GLU A 138
THR A 152
ILE A 195
 None
 1.00A 3gcsA-2x1mA:
undetectable		 3gcsA-2x1mA:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z6i TRANS-2-ENOYL-ACP
REDUCTASE II

(Streptococcus
pneumoniae) 		PF03060
(NMO) 		5 VAL A 157
ALA A 136
LEU A   8
ILE A 114
HIS A 107
 None
 0.86A 3gcsA-2z6iA:
undetectable		 3gcsA-2z6iA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zv7 TYROSINE-PROTEIN
KINASE LYN

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		5 VAL A 261
ALA A 273
LEU A 293
THR A 319
HIS A 365
 None
 1.03A 3gcsA-2zv7A:
20.1		 3gcsA-2zv7A:
25.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zv7 TYROSINE-PROTEIN
KINASE LYN

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		5 VAL A 261
ALA A 273
THR A 319
ILE A 358
HIS A 365
 None
 0.97A 3gcsA-2zv7A:
20.1		 3gcsA-2zv7A:
25.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c1x HEPATOCYTE GROWTH
FACTOR RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A1092
ALA A1108
GLU A1127
HIS A1202
ASP A1222
 CKK  A1500 ( 4.3A)
CKK  A1500 (-3.2A)
CKK  A1500 (-3.4A)
CKK  A1500 (-4.2A)
CKK  A1500 (-4.5A)
 0.79A 3gcsA-3c1xA:
20.2		 3gcsA-3c1xA:
22.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3coi MITOGEN-ACTIVATED
PROTEIN KINASE 13

(Homo sapiens) 		PF00069
(Pkinase) 		6 VAL A  39
ALA A  52
GLU A  72
LEU A  76
HIS A 148
LEU A 167
 None
 0.95A 3gcsA-3coiA:
38.3		 3gcsA-3coiA:
61.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3coi MITOGEN-ACTIVATED
PROTEIN KINASE 13

(Homo sapiens) 		PF00069
(Pkinase) 		7 VAL A  39
ALA A  52
LEU A  75
LEU A  76
ILE A 141
HIS A 148
LEU A 167
 None
 0.92A 3gcsA-3coiA:
38.3		 3gcsA-3coiA:
61.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3coi MITOGEN-ACTIVATED
PROTEIN KINASE 13

(Homo sapiens) 		PF00069
(Pkinase) 		7 VAL A  39
ALA A  52
LEU A  76
ILE A  85
ILE A 141
HIS A 148
LEU A 167
 None
 0.88A 3gcsA-3coiA:
38.3		 3gcsA-3coiA:
61.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3e7o MITOGEN-ACTIVATED
PROTEIN KINASE 9

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  40
ALA A  53
ARG A  72
LEU A  77
HIS A 149
 35F  A   1 ( 4.8A)
35F  A   1 (-3.6A)
None
None
None
 0.95A 3gcsA-3e7oA:
34.4		 3gcsA-3e7oA:
50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fww BIFUNCTIONAL PROTEIN
GLMU

(Yersinia pestis) 		PF00132
(Hexapep)
PF12804
(NTP_transf_3) 		5 ALA A 330
LEU A 298
ILE A 309
THR A 313
ILE A 272
 None
 1.01A 3gcsA-3fwwA:
undetectable		 3gcsA-3fwwA:
21.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		8 ALA A  51
GLU A  71
LEU A  75
THR A 106
ILE A 141
HIS A 148
LEU A 167
ASP A 168
 NIL  A   1 (-3.7A)
NIL  A   1 (-3.7A)
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
None
NIL  A   1 (-4.3A)
NIL  A   1 (-4.0A)
NIL  A   1 (-4.6A)
 0.79A 3gcsA-3gp0A:
40.6		 3gcsA-3gp0A:
74.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		7 ALA A  51
LEU A  74
LEU A  75
THR A 106
ILE A 141
HIS A 148
ASP A 168
 NIL  A   1 (-3.7A)
None
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
None
NIL  A   1 (-4.3A)
NIL  A   1 (-4.6A)
 0.76A 3gcsA-3gp0A:
40.6		 3gcsA-3gp0A:
74.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		8 ALA A  51
LEU A  75
ILE A  84
THR A 106
ILE A 141
HIS A 148
LEU A 167
ASP A 168
 NIL  A   1 (-3.7A)
NIL  A   1 ( 4.8A)
NIL  A   1 (-4.4A)
NIL  A   1 (-3.3A)
None
NIL  A   1 (-4.3A)
NIL  A   1 (-4.0A)
NIL  A   1 (-4.6A)
 0.80A 3gcsA-3gp0A:
40.6		 3gcsA-3gp0A:
74.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gp0 MITOGEN-ACTIVATED
PROTEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  38
ALA A  51
LEU A  74
LEU A  75
THR A 106
 NIL  A   1 ( 4.7A)
NIL  A   1 (-3.7A)
None
NIL  A   1 ( 4.8A)
NIL  A   1 (-3.3A)
 0.61A 3gcsA-3gp0A:
40.6		 3gcsA-3gp0A:
74.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hmu AMINOTRANSFERASE,
CLASS III

(Ruegeria
pomeroyi) 		PF00202
(Aminotran_3) 		6 ALA A 126
GLU A 228
ILE A 226
THR A 287
HIS A 184
LEU A 166
 None
 1.39A 3gcsA-3hmuA:
undetectable		 3gcsA-3hmuA:
22.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oht P38A

(Salmo salar) 		PF00069
(Pkinase) 		5 ALA A  52
GLU A  72
LEU A  76
THR A 107
LEU A 168
 1N1  A1000 (-3.7A)
1N1  A1000 (-4.2A)
1N1  A1000 (-4.7A)
1N1  A1000 (-3.3A)
1N1  A1000 ( 3.7A)
 0.96A 3gcsA-3ohtA:
16.4		 3gcsA-3ohtA:
83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oht P38A

(Salmo salar) 		PF00069
(Pkinase) 		7 ALA A  52
LEU A  75
LEU A  76
ILE A  85
THR A 107
ILE A 142
LEU A 168
 1N1  A1000 (-3.7A)
None
1N1  A1000 (-4.7A)
1N1  A1000 ( 4.1A)
1N1  A1000 (-3.3A)
None
1N1  A1000 ( 3.7A)
 0.74A 3gcsA-3ohtA:
16.4		 3gcsA-3ohtA:
83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oht P38A

(Salmo salar) 		PF00069
(Pkinase) 		7 VAL A  39
ALA A  52
LEU A  75
LEU A  76
ILE A  85
THR A 107
ILE A 142
 1N1  A1000 (-4.6A)
1N1  A1000 (-3.7A)
None
1N1  A1000 (-4.7A)
1N1  A1000 ( 4.1A)
1N1  A1000 (-3.3A)
None
 0.72A 3gcsA-3ohtA:
16.4		 3gcsA-3ohtA:
83.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3omv RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 373
GLU A 393
LEU A 397
THR A 421
HIS A 466
 SM5  A   1 (-3.6A)
SM5  A   1 (-4.3A)
None
SM5  A   1 (-4.4A)
None
 0.89A 3gcsA-3omvA:
19.9		 3gcsA-3omvA:
27.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3omv RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 363
ALA A 373
GLU A 393
LEU A 397
THR A 421
 SM5  A   1 (-4.0A)
SM5  A   1 (-3.6A)
SM5  A   1 (-4.3A)
None
SM5  A   1 (-4.4A)
 0.59A 3gcsA-3omvA:
19.9		 3gcsA-3omvA:
27.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pg1 MITOGEN-ACTIVATED
PROTEIN KINASE,
PUTATIVE (MAP
KINASE-LIKE PROTEIN)

(Leishmania
major) 		PF00069
(Pkinase) 		5 VAL A  37
ALA A  49
LEU A  82
THR A 112
HIS A 156
 None
 0.32A 3gcsA-3pg1A:
24.7		 3gcsA-3pg1A:
36.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q5i PROTEIN KINASE

(Plasmodium
berghei) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		5 ALA A  84
LEU A 119
ILE A 128
THR A 144
HIS A 188
 ANP  A1634 (-3.6A)
None
None
ANP  A1634 (-4.6A)
None
 0.93A 3gcsA-3q5iA:
22.0		 3gcsA-3q5iA:
27.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q5i PROTEIN KINASE

(Plasmodium
berghei) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		6 VAL A  71
ALA A  84
GLU A 115
LEU A 119
ILE A 128
THR A 144
 ANP  A1634 (-4.1A)
ANP  A1634 (-3.6A)
None
None
None
ANP  A1634 (-4.6A)
 0.99A 3gcsA-3q5iA:
22.0		 3gcsA-3q5iA:
27.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qi6 CYSTATHIONINE
GAMMA-SYNTHASE METB
(CGS)

(Mycobacterium
ulcerans) 		PF01053
(Cys_Met_Meta_PP) 		5 LEU A  98
LEU A  94
ILE A 118
THR A 114
HIS A 103
 None
 0.93A 3gcsA-3qi6A:
undetectable		 3gcsA-3qi6A:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v5q NT-3 GROWTH FACTOR
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 VAL A 552
ALA A 570
GLU A 588
LEU A 591
LEU A 592
HIS A 677
ASP A 697
 None
0F4  A 902 (-3.2A)
0F4  A 902 (-3.6A)
None
0F4  A 902 (-4.7A)
0F4  A 902 (-4.1A)
None
 1.02A 3gcsA-3v5qA:
20.3		 3gcsA-3v5qA:
25.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v5q NT-3 GROWTH FACTOR
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 552
ALA A 570
LEU A 595
LEU A 592
HIS A 677
ASP A 697
 None
0F4  A 902 (-3.2A)
0F4  A 902 ( 4.8A)
0F4  A 902 (-4.7A)
0F4  A 902 (-4.1A)
None
 1.46A 3gcsA-3v5qA:
20.3		 3gcsA-3v5qA:
25.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 866
GLU A 885
LEU A 889
HIS A1026
ASP A1046
 4TT  A2001 (-3.5A)
None
None
None
None
 0.84A 3gcsA-3vidA:
3.1		 3gcsA-3vidA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3waj TRANSMEMBRANE
OLIGOSACCHARYL
TRANSFERASE

(Archaeoglobus
fulgidus) 		PF02516
(STT3) 		5 VAL A 239
ALA A 241
LEU A 174
LEU A 178
ILE A 221
 None
 1.02A 3gcsA-3wajA:
undetectable		 3gcsA-3wajA:
16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 653
GLU A 672
THR A 701
HIS A 764
ASP A 784
 DI1  A1000 (-3.6A)
DI1  A1000 (-3.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-3.8A)
DI1  A1000 (-4.1A)
 0.73A 3gcsA-4ckrA:
20.9		 3gcsA-4ckrA:
24.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 653
ILE A 685
THR A 701
HIS A 764
ASP A 784
 DI1  A1000 (-3.6A)
DI1  A1000 (-4.5A)
DI1  A1000 (-3.6A)
DI1  A1000 (-3.8A)
DI1  A1000 (-4.1A)
 0.81A 3gcsA-4ckrA:
20.9		 3gcsA-4ckrA:
24.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 624
ALA A 653
ILE A 685
THR A 701
HIS A 764
 DI1  A1000 (-4.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-4.5A)
DI1  A1000 (-3.6A)
DI1  A1000 (-3.8A)
 0.99A 3gcsA-4ckrA:
20.9		 3gcsA-4ckrA:
24.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gq1 NUP37

(Schizosaccharomyces
pombe) 		PF00400
(WD40) 		5 LEU A  74
LEU A 103
ILE A  65
THR A 117
HIS A  37
 None
 1.01A 3gcsA-4gq1A:
undetectable		 3gcsA-4gq1A:
22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hxq ARGINASE-1

(Homo sapiens) 		PF00491
(Arginase) 		5 LEU A 273
LEU A 270
ILE A 264
THR A 267
ILE A 299
 None
 0.97A 3gcsA-4hxqA:
undetectable		 3gcsA-4hxqA:
22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kqn D-HYDANTOINASE

(Bacillus sp.
AR9) 		PF01979
(Amidohydro_1) 		5 GLU A  99
LEU A 101
ILE A 126
THR A 165
ILE A 146
 GLU  A  99 ( 0.6A)
LEU  A 101 ( 0.6A)
ILE  A 126 ( 0.6A)
THR  A 165 ( 0.8A)
ILE  A 146 ( 0.7A)
 1.02A 3gcsA-4kqnA:
undetectable		 3gcsA-4kqnA:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p2k EPHRIN TYPE-A
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM) 		5 VAL A 627
ALA A 644
GLU A 663
ILE A 676
THR A 692
 None
 1.03A 3gcsA-4p2kA:
9.5		 3gcsA-4p2kA:
24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q7a N-ACETYL-ORNITHINE/N
-ACETYL-LYSINE
DEACETYLASE

(Sphaerobacter
thermophilus) 		PF01546
(Peptidase_M20) 		6 ALA A 106
GLU A 341
LEU A 337
THR A 102
LEU A  15
ASP A  14
 None
 1.47A 3gcsA-4q7aA:
undetectable		 3gcsA-4q7aA:
21.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE

(Leishmania
donovani) 		PF00069
(Pkinase) 		5 ALA A  49
LEU A  74
ILE A  83
ILE A 140
HIS A 147
 ANP  A 402 (-3.3A)
None
ANP  A 402 (-4.8A)
None
None
 1.03A 3gcsA-4qnyA:
32.4		 3gcsA-4qnyA:
38.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qtb MITOGEN-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  56
ALA A  69
GLU A  88
LEU A  92
ILE A 101
 None
38Z  A 418 (-3.4A)
38Z  A 418 (-3.4A)
None
38Z  A 418 ( 4.9A)
 1.01A 3gcsA-4qtbA:
28.1		 3gcsA-4qtbA:
47.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tv6 2-DEHYDRO-3-DEOXYGLU
CARATE ALDOLASE

(Staphylococcus
aureus) 		PF03328
(HpcH_HpaI) 		5 ARG A  90
ILE A  43
THR A  45
ILE A  67
LEU A  58
 None
 0.96A 3gcsA-4tv6A:
undetectable		 3gcsA-4tv6A:
21.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		6 GLU B  71
LEU B  74
LEU B  75
THR B 106
LEU B 167
ASP B 168
 39G  B 401 (-3.4A)
None
39G  B 401 (-4.3A)
39G  B 401 (-3.6A)
39G  B 401 (-3.6A)
39G  B 401 (-3.5A)
 1.26A 3gcsA-4tyhB:
29.9		 3gcsA-4tyhB:
98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		5 LEU B  75
ILE B  84
THR B 106
LEU B 167
ASP B 168
 39G  B 401 (-4.3A)
39G  B 401 ( 3.8A)
39G  B 401 (-3.6A)
39G  B 401 (-3.6A)
39G  B 401 (-3.5A)
 0.95A 3gcsA-4tyhB:
29.9		 3gcsA-4tyhB:
98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		9 VAL B  38
ALA B  51
GLU B  71
LEU B  74
LEU B  75
THR B 106
ILE B 141
HIS B 148
LEU B 167
 None
39G  B 401 (-3.5A)
39G  B 401 (-3.4A)
None
39G  B 401 (-4.3A)
39G  B 401 (-3.6A)
None
None
39G  B 401 (-3.6A)
 0.95A 3gcsA-4tyhB:
29.9		 3gcsA-4tyhB:
98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		8 VAL B  38
ALA B  51
LEU B  75
ILE B  84
THR B 106
ILE B 141
HIS B 148
LEU B 167
 None
39G  B 401 (-3.5A)
39G  B 401 (-4.3A)
39G  B 401 ( 3.8A)
39G  B 401 (-3.6A)
None
None
39G  B 401 (-3.6A)
 0.81A 3gcsA-4tyhB:
29.9		 3gcsA-4tyhB:
98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tyh MITOGEN-ACTIVATED
PROTEIN KINASE 14

(Mus musculus) 		PF00069
(Pkinase) 		5 VAL B 117
LEU B 164
ILE B 134
ILE B 141
HIS B 148
 None
 0.90A 3gcsA-4tyhB:
29.9		 3gcsA-4tyhB:
98.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uvj COHESIN SUBUNIT SCC3

(Saccharomyces
cerevisiae) 		no annotation 6 VAL A 907
ALA A 971
LEU A1030
ILE A 938
ILE A 943
ASP A 936
 None
 1.29A 3gcsA-4uvjA:
undetectable		 3gcsA-4uvjA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wgk NEUTRAL CERAMIDASE

(Homo sapiens) 		PF04734
(Ceramidase_alk)
PF17048
(Ceramidse_alk_C) 		5 VAL A 435
ALA A 605
LEU A 613
ILE A 189
ASP A 523
 None
 0.83A 3gcsA-4wgkA:
undetectable		 3gcsA-4wgkA:
18.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xrl MITOGEN-ACTIVATED
PROTEIN KINASE 1

(Rattus
norvegicus) 		PF00069
(Pkinase) 		6 VAL A  37
ALA A  50
GLU A  69
LEU A  73
ILE A  82
ILE A 138
 None
42A  A 402 (-3.2A)
None
None
None
None
 1.08A 3gcsA-4xrlA:
35.6		 3gcsA-4xrlA:
46.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xrl MITOGEN-ACTIVATED
PROTEIN KINASE 1

(Rattus
norvegicus) 		PF00069
(Pkinase) 		5 VAL A  37
ALA A  50
ILE A  82
ILE A 138
HIS A 145
 None
42A  A 402 (-3.2A)
None
None
None
 0.88A 3gcsA-4xrlA:
35.6		 3gcsA-4xrlA:
46.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zsl MITOGEN-ACTIVATED
PROTEIN KINASE 7

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  82
GLU A 102
LEU A 106
ILE A 115
ASP A 200
 None
4QZ  A 401 (-4.3A)
4QZ  A 401 ( 4.7A)
None
None
 1.01A 3gcsA-4zslA:
34.7		 3gcsA-4zslA:
44.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zsl MITOGEN-ACTIVATED
PROTEIN KINASE 7

(Homo sapiens) 		PF00069
(Pkinase) 		5 VAL A  69
ALA A  82
GLU A 102
LEU A 106
ILE A 115
 None
None
4QZ  A 401 (-4.3A)
4QZ  A 401 ( 4.7A)
None
 0.88A 3gcsA-4zslA:
34.7		 3gcsA-4zslA:
44.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a31 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 1

(Homo sapiens) 		PF12859
(ANAPC1) 		5 ALA A1477
LEU A1406
LEU A1409
HIS A1602
LEU A1588
 None
 0.91A 3gcsA-5a31A:
undetectable		 3gcsA-5a31A:
13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ex6 CYTOCHROME P450

(Streptomyces
toyocaensis) 		no annotation 5 LEU C 139
LEU C 394
ILE C 391
THR C 380
LEU C 247
 None
 0.98A 3gcsA-5ex6C:
undetectable		 3gcsA-5ex6C:
23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gn1 ATP-DEPENDENT
HELICASE FUN30

(Saccharomyces
cerevisiae) 		PF00176
(SNF2_N)
PF00271
(Helicase_C) 		5 LEU A 927
LEU A 924
ILE A 890
ILE A 897
ASP A 915
 None
 0.82A 3gcsA-5gn1A:
undetectable		 3gcsA-5gn1A:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gqf LACTO-N-BIOSIDASE

(Bifidobacterium
longum) 		no annotation 5 ALA A 547
LEU A 554
ILE A 502
LEU A 621
ASP A 620
 None
 1.00A 3gcsA-5gqfA:
undetectable		 3gcsA-5gqfA:
19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l6o EPHRIN TYPE-B
RECEPTOR 3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 VAL A 647
ALA A 663
ILE A 695
THR A 711
HIS A 756
ASP A 776
 None
6P6  A1001 (-3.3A)
None
6P6  A1001 (-3.5A)
DIO  A1002 (-4.1A)
None
 1.03A 3gcsA-5l6oA:
20.5		 3gcsA-5l6oA:
25.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m3q EUKARYOTIC
TRANSLATION
INITIATION FACTOR 6

(Chaetomium
thermophilum) 		PF01912
(eIF-6) 		5 VAL A 135
ALA A 115
LEU A  25
ILE A  53
LEU A  71
 None
 1.01A 3gcsA-5m3qA:
undetectable		 3gcsA-5m3qA:
23.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tov ADENOSYLHOMOCYSTEINA
SE

(Thermotoga
maritima) 		PF00670
(AdoHcyase_NAD)
PF05221
(AdoHcyase) 		5 GLU A 138
LEU A 147
ILE A 111
LEU A 118
ASP A 117
 None
 1.02A 3gcsA-5tovA:
undetectable		 3gcsA-5tovA:
25.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tr0 SEED LINOLEATE
13S-LIPOXYGENASE-1

(Glycine max) 		no annotation 5 ALA A 652
LEU A 527
LEU A 528
ILE A 682
ILE A 621
 None
 1.00A 3gcsA-5tr0A:
undetectable		 3gcsA-5tr0A:
18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w21 KLOTHO

(Homo sapiens) 		no annotation 5 ALA A 297
LEU A 380
LEU A 375
ILE A 303
LEU A 324
 None
 0.96A 3gcsA-5w21A:
undetectable		 3gcsA-5w21A:
10.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x1t PPKA-294

(Serratia sp.
FS14) 		no annotation 5 VAL A  37
ALA A  50
THR A 118
ILE A 156
HIS A 163
 ADP  A 401 ( 4.5A)
ADP  A 401 (-3.4A)
ADP  A 401 (-4.1A)
None
None
 0.85A 3gcsA-5x1tA:
19.3		 3gcsA-5x1tA:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xzw SERINE/THREONINE-PRO
TEIN KINASE RAD53

(Saccharomyces
cerevisiae) 		no annotation 5 VAL A 212
ALA A 225
GLU A 244
LEU A 248
ILE A 310
 None
 0.85A 3gcsA-5xzwA:
17.9		 3gcsA-5xzwA:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c9b PLP-DEPENDENT
L-ARGININE
HYDROXYLASE MPPP

(Streptomyces
wadayamensis) 		no annotation 5 LEU A 129
LEU A 110
ILE A 118
THR A 156
ASP A 120
 None
None
None
LLP  A 221 ( 3.5A)
None
 1.01A 3gcsA-6c9bA:
undetectable		 3gcsA-6c9bA:
13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cfp UBIQUITIN-LIKE
PROTEIN
SMT3,POLYMERASE
ACIDIC PROTEIN

(Influenza A
virus;
Saccharomyces
cerevisiae) 		no annotation 5 ALA A 439
LEU A 641
ILE A 428
ILE A 459
LEU A 586
 None
 1.01A 3gcsA-6cfpA:
undetectable		 3gcsA-6cfpA:
12.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cnh SERINE/THREONINE-PRO
TEIN KINASE PRP4
HOMOLOG

(Homo sapiens) 		no annotation 5 ALA A 715
GLU A 732
LEU A 736
HIS A 813
ASP A 834
 919  A1101 (-3.5A)
919  A1101 (-3.7A)
None
919  A1101 (-4.2A)
919  A1101 (-4.5A)
 0.82A 3gcsA-6cnhA:
25.5		 3gcsA-6cnhA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cnh SERINE/THREONINE-PRO
TEIN KINASE PRP4
HOMOLOG

(Homo sapiens) 		no annotation 5 VAL A 701
ALA A 715
LEU A 736
HIS A 813
ASP A 834
 919  A1101 (-4.7A)
919  A1101 (-3.5A)
None
919  A1101 (-4.2A)
919  A1101 (-4.5A)
 0.72A 3gcsA-6cnhA:
25.5		 3gcsA-6cnhA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cz4 PROTEIN-TYROSINE
KINASE 6

(Homo sapiens) 		no annotation 5 VAL A 205
ALA A 217
THR A 264
HIS A 310
ASP A 330
 FKY  A9001 ( 4.6A)
FKY  A9001 (-3.3A)
FKY  A9001 (-3.0A)
FKY  A9001 (-3.9A)
None
 0.59A 3gcsA-6cz4A:
20.0		 3gcsA-6cz4A:
14.20